RESMED INC - Common Stock (RMD)

Historical Holders from Q1 2014 to Q3 2025

Symbol
RMD on NYSE
CUSIP
761152107
Type / Class
Equity / Common Stock
Shares outstanding
146M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
91.4M
Holdings value
$25B
% of all portfolios
0.018%
Grand Portfolio weight change
0%
Number of holders
926
Number of buys
445
Number of sells
-391
Average Value change %
0%
Average buys %
+0.002%
Average sells %
-0.003%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of RESMED INC - Common Stock (RMD)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD GROUP INC 13.66% $5.48B 20M The Vanguard Group Sep 30, 2025

Institutional Holders of RESMED INC - Common Stock (RMD)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 91.4M $25B -$145M $273.73 926
2025 Q2 92.1M $23.8B -$257M $258.00 910
2025 Q1 93.2M $20.8B +$661M $223.85 869
2024 Q4 90M $20.6B +$631M $228.69 853
2024 Q3 86.2M $21B +$210M $244.12 791
2024 Q2 85.5M $16.4B +$749M $191.42 767
2024 Q1 81.3M $16.1B +$250M $198.03 708
2023 Q4 80.1M $13.8B -$1.05B $172.02 674
2023 Q3 86.2M $12.7B -$1.9B $147.87 644
2023 Q2 94.9M $20.7B -$127M $218.50 715
2023 Q1 95.2M $20.8B +$79.1M $218.99 657
2022 Q4 95.1M $19.8B -$204M $208.13 707
2022 Q3 96M $21B -$63.9M $218.30 644
2022 Q2 96.3M $20.2B -$217M $209.63 656
2022 Q1 97.1M $23.6B +$638M $242.51 657
2021 Q4 94.4M $24.6B -$542M $260.48 701
2021 Q3 96.1M $25.3B -$115M $263.55 670
2021 Q2 96.5M $23.8B -$549M $246.52 649
2021 Q1 98.9M $19.2B -$372M $194.02 645
2020 Q4 101M $21.5B +$125M $212.56 651
2020 Q3 100M $17.2B -$283M $171.43 609
2020 Q2 102M $19.6B +$693M $192.00 570
2020 Q1 98.3M $14.5B +$119M $147.29 570
2019 Q4 97.6M $15.1B +$143M $154.97 552
2019 Q3 96.6M $13B +$38.5M $135.11 517
2019 Q2 96.3M $11.7B +$25M $122.03 475
2019 Q1 97.5M $10.1B -$15.3M $103.97 470
2018 Q4 97.5M $11.1B +$397M $113.87 492
2018 Q3 94M $10.8B +$178M $115.34 488
2018 Q2 92.4M $9.58B +$227M $103.58 456
2018 Q1 90.2M $8.88B +$144M $98.47 436
2017 Q4 89.3M $7.56B +$29.2M $84.69 410
2017 Q3 88.8M $6.83B +$166M $76.96 360
2017 Q2 86.7M $6.75B +$42.6M $77.87 335
2017 Q1 86.8M $6.24B +$814M $71.97 367
2016 Q4 88.1M $5.46B -$132M $62.05 357
2016 Q3 90M $5.83B +$198M $64.79 368
2016 Q2 87M $5.5B +$227M $63.23 355
2016 Q1 83.5M $4.82B +$24.2M $57.82 368
2015 Q4 82.8M $4.45B +$287M $53.69 346
2015 Q3 77.2M $3.92B +$126M $50.96 307
2015 Q2 74.5M $4.2B +$8.13M $56.37 309
2015 Q1 73.3M $5.26B -$62.6M $71.78 325
2014 Q4 74.7M $4.19B +$81.7M $56.06 308
2014 Q3 72.7M $3.58B -$145M $49.27 296
2014 Q2 75.6M $3.83B -$208M $50.63 310
2014 Q1 79.9M $3.57B +$4.31M $44.69 316